The Effect of Oral Acetaminophen on Open Arterial Duct Closure in Premature Infants Less Than 32 Weeks

1. Jasani B, Weisz DE, McNamara PJ. Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants. Semin Perinatol 2018; 42(4):243–52. Jasani B Weisz DE McNamara PJ . Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants . Semin Perinatol 2018 ; 42 ( 4 ): 243 – 52 . Search in Google Scholar

2. De Klerk JC, Engbers AG, Van Beek F, et al. Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review. Front Pediatr 2020; 8:541. De Klerk JC Engbers AG Van Beek F . Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review . Front Pediatr 2020 ; 8 : 541 . Search in Google Scholar

3. Fink D, Nitzan I, Bin-Nun A, et al. Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates. J Perinatol 2018; 38(11):1526–31. Fink D Nitzan I Bin-Nun A . Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates . J Perinatol 2018 ; 38 ( 11 ): 1526 – 31 . Search in Google Scholar

4. Hundscheid T, Onland W, Overmeire B Van, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr 2018; 18:262. doi: 10.1186/s12887-018-1215-7 Hundscheid T Onland W Overmeire B Van . Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial) . BMC Pediatr 2018 ; 18 : 262 . doi: 10.1186/s12887-018-1215-7 Open DOISearch in Google Scholar

5. Faim DRO, Tiago JAM, Castelo RJS, et al. Patent ductus arteriosus closure: Experience from a tertiary referral center. Rev Paul Pediatr 2020; 39:e2020013. doi: 10.1590/1984-0462/2021/39/2020013 Faim DRO Tiago JAM Castelo RJS . Patent ductus arteriosus closure: Experience from a tertiary referral center . Rev Paul Pediatr 2020 ; 39 : e2020013 . doi: 10.1590/1984-0462/2021/39/2020013 Open DOISearch in Google Scholar

6. El-Mashad AE, El-Mahdy H, Amrousy D El, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 2017; 176:233–40. doi: 10.1007/s00431-016-2830-7 El-Mashad AE El-Mahdy H Amrousy D El . Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates . Eur J Pediatr 2017 ; 176 : 233 – 40 . doi: 10.1007/s00431-016-2830-7 Open DOISearch in Google Scholar

7. Bardanzellu F, Neroni P, Dessì A, et al. Paracetamol in patent ductus arteriosus treatment: efficacious and safe? Biomed Res Int 2017; 2017:1438038. doi: 10.1155/2017/1438038. Bardanzellu F Neroni P Dessì A . Paracetamol in patent ductus arteriosus treatment: efficacious and safe? Biomed Res Int 2017 ; 2017 : 1438038 . doi: 10.1155/2017/1438038 . Open DOISearch in Google Scholar

8. Al-lawama M, Alammori I, Abdelghani T, et al. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res 2018; 46:811–8. doi: 10.1177/0300060517722698 Al-lawama M Alammori I Abdelghani T . Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus . J Int Med Res 2018 ; 46 : 811 – 8 . doi: 10.1177/0300060517722698 Open DOISearch in Google Scholar

9. Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med 2016; 12:2531–6. doi: 10.3892/etm.2016.3676 Yang B Gao X Ren Y . Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial . Exp Ther Med 2016 ; 12 : 2531 – 6 . doi: 10.3892/etm.2016.3676 Open DOISearch in Google Scholar

10. Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE 2013; 8:e77888. doi: 10.1371/journal.pone.0077888 Dang D Wang D Zhang C . Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial . PLoS ONE 2013 ; 8 : e77888 . doi: 10.1371/journal.pone.0077888 Open DOISearch in Google Scholar

11. Karabulut B, Paytoncu S. Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants. Pediatr Drugs 2019; 21:113–21. Karabulut B Paytoncu S . Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants . Pediatr Drugs 2019 ; 21 : 113 – 21 . Search in Google Scholar

12. Nemerofsky SL, Parravicini E, Bateman D, et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol 2008; 25:661–6. Nemerofsky SL Parravicini E Bateman D . The ductus arteriosus rarely requires treatment in infants > 1000 grams . Am J Perinatol 2008 ; 25 : 661 – 6 . Search in Google Scholar

13. Vaidya R, Knee A, Paris Y, et al. Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants. J Perinatol 2021; 41(5):998–1006. Vaidya R Knee A Paris Y . Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants . J Perinatol 2021 ; 41 ( 5 ): 998 – 1006 . Search in Google Scholar

14. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 2018; (4). Ohlsson A Shah PS . Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants . Cochrane Database Syst Rev 2018 ; ( 4 ). Search in Google Scholar

15. Aikio O, Harkin P, Saarela T, et al. Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J Matern-Fetal Neonatal Med 2014; 27(12):1252–6. Aikio O Harkin P Saarela T . Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants . J Matern-Fetal Neonatal Med 2014 ; 27 ( 12 ): 1252 – 6 . Search in Google Scholar

16. Terrin G, Conte F, Oncel MY, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: A systematic review and metaanalysis. Arch Dis Child: Fetal Neonatal Ed 2016; 101(2):F127–36. Terrin G Conte F Oncel MY . Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: A systematic review and metaanalysis . Arch Dis Child: Fetal Neonatal Ed 2016 ; 101 ( 2 ): F127 – 36 . Search in Google Scholar

17. Höck M, Brunner B, Rier V, et al. Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants: Impact on outcome and pain perception. Pediatr Neonatol 2020; 61(1):84–91. Höck M Brunner B Rier V . Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants: Impact on outcome and pain perception . Pediatr Neonatol 2020 ; 61 ( 1 ): 84 – 91 . Search in Google Scholar

18. Dash SK, Kabra NS, Avasthi BS, et al. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial. Indian Pediatr 2015; 52(7):573–8. doi: 10.1007/s13312-015-0677-z Dash SK Kabra NS Avasthi BS . Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial . Indian Pediatr 2015 ; 52 ( 7 ): 573 – 8 . doi: 10.1007/s13312-015-0677-z Open DOISearch in Google Scholar

19. Härkin P, Härmä A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: A randomized trial. J Pediatr 2016; 177:72–7. Härkin P Härmä A Aikio O . Paracetamol accelerates closure of the ductus arteriosus after premature birth: A randomized trial . J Pediatr 2016 ; 177 : 72 – 7 . Search in Google Scholar

20. Bagheri MM, Bahman-Bijari B, Torabi-Nejad MH, et al. Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iran J Pediatr 2018; 28(4). Bagheri MM Bahman-Bijari B Torabi-Nejad MH . Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial . Iran J Pediatr 2018 ; 28 ( 4 ). Search in Google Scholar

21. Schindler T, Smyth J, Bolisetty S, et al. Early Paracetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatol 2021; 118:274–81. doi: 10.1159/000515415 Schindler T Smyth J Bolisetty S . Early Paracetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants . Neonatol 2021 ; 118 : 274 – 81 . doi: 10.1159/000515415 Open DOISearch in Google Scholar

22. Davidson JM, Ferguson J, Ivey E, et al. A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants [published online ahead of print, 2020]. J Perinatol. doi: 10.1038/s41372-020-0694-1 Davidson JM Ferguson J Ivey E . A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants [published online ahead of print, 2020] . J Perinatol . doi: 10.1038/s41372-020-0694-1 Open DOISearch in Google Scholar

23. Asbagh PA, Zarkesh MR, Nili F, et al. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial. Tehran Univ Med J 2015; 73(2). Asbagh PA Zarkesh MR Nili F . Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial . Tehran Univ Med J 2015 ; 73 ( 2 ). Search in Google Scholar

24. Herrman K, Bose C, Lewis K, et al. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child: Fetal Neonatal Ed 2009; 94(1):F48–50. Herrman K Bose C Lewis K . Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit . Arch Dis Child: Fetal Neonatal Ed 2009 ; 94 ( 1 ): F48 – 50 . Search in Google Scholar

25. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30(4):241–52. Benitz WE . Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010 ; 30 ( 4 ): 241 – 52 . Search in Google Scholar

26. Semberova J, Sirc J, Miletin J, et al. Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g. Pediatr 2017; 140(2). Semberova J Sirc J Miletin J . Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g . Pediatr 2017 ; 140 ( 2 ). Search in Google Scholar

27. Goyal R, Goyal D, Longo LD, et al. Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition. Pediatr Res 2016; 80(4):610–8. Goyal R Goyal D Longo LD . Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition . Pediatr Res 2016 ; 80 ( 4 ): 610 – 8 . Search in Google Scholar

28. Hamrick SE, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant. Pediatr 2020; 146(5). Hamrick SE Sallmon H Rose AT . Patent ductus arteriosus of the preterm infant . Pediatr 2020 ; 146 ( 5 ). Search in Google Scholar

29. Olsson KW, Jonzon A, Sindelar R. A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22–27 weeks gestational age. Crit Care Res Pract 2012; 2012:715265. Olsson KW Jonzon A Sindelar R . A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22–27 weeks gestational age . Crit Care Res Pract 2012 ; 2012 : 715265 . Search in Google Scholar

30. Kumar J, Dutta S, Sundaram V, et al. Platelet transfusion for PDA closure in preterm infants: A randomized controlled trial. Pediatr 2019; 143(5):e20182565. Kumar J Dutta S Sundaram V . Platelet transfusion for PDA closure in preterm infants: A randomized controlled trial . Pediatr 2019 ; 143 ( 5 ): e20182565 . Search in Google Scholar

31. Kahvecioglu D, Erdeve O, Akduman H, et al. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in prematurity. Pediatr Neonatol 2018; 59(1):53–7. Kahvecioglu D Erdeve O Akduman H . Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in prematurity . Pediatr Neonatol 2018 ; 59 ( 1 ): 53 – 7 . Search in Google Scholar